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Abstract 
Aims/hypothesis: The enteroviral capsid protein, vp1, was recently shown to be present in some beta cells in more than 60% of patients with recent-onset type 1 diabetes but in very few age matched controls. The rate of proliferation of islet cells was also markedly increased in the type 1 diabetic patients. Since it has been suggested that enteroviruses replicate most efficiently in proliferating cells, we have investigated whether vp1 is preferentially present in proliferating beta cells in type 1 diabetes. 
Methods: Combined immunoperoxidase and immunofluorescence staining was used to record the presence of enteroviral vp1, insulin and Ki67 in the islets of recent-onset type 1 diabetic patients.
Results: Among a total of 1175 islets, 359 (30.5%) contained insulin. Vp1 expressing endocrine cells were found in 72 islets (6.1% of (​mailto:6.1@of​) total), all of which retained insulin.  Ki67+ endocrine cells were present in 52 (4.4%) islets, with 44 (84.6%) of these being insulin positive. Overall, 28 of 1175 (2.4%) islets contained both Ki67+ cells and vp1+ cells. Dual positivity of these markers accounted for 38.9% of the total vp1+ islets and 53.8% of the total Ki67+ islets. No individual islet cells were dual positive for Ki67 and vp1.
Conclusions/interpretation: Ki67+ cells were frequently observed in islets which also contained vp1+ cells, suggesting that the factors facilitating viral replication may also drive islet cell proliferation. However, in an individual cell, vp1 production does not require concurrent beta cell proliferation.
Key Words: Beta cell, enterovirus, Ki67, proliferation, type 1 diabetes, vp1. 
Abbreviations: PKR: protein kinase R, DAB: 3,3’-diaminobenzidine.

Introduction
Enteroviral infections have been increasingly implicated in the pathogenesis of type 1 diabetes  ADDIN EN.CITE [1-3]. In support of this, we have demonstrated the presence of the enteroviral capsid protein, vp1, in multiple islets of a majority of recent-onset type 1 diabetic patients [4]. Vp1 correlated strongly with other markers of viral infection, including the up-regulation of protein kinase R (PKR), consistent with the presence of active virus in the islet cells of patients with type 1 diabetes. Importantly, however, there was no evidence of large scale islet cell lysis in the patients suggesting that the enteroviral infection of beta cells established in type 1 diabetes is atypical and represents a persistent, non cytopathic infection. On this basis, we have proposed that the immunopositivity for vp1 in islet cells may represent only “the tip of the iceberg” of a larger, more covert, infection persisting at the level of viral RNA [4]. This is important because it has been reported that vp1 production and the assembly of infectious enterovirus are minimised in quiescent cells, whereas they occur extensively in actively cycling cells [5]. This raises the possibility that activation of cell proliferation may be required for re-initiation of viral protein production after the establishment of a persistent infection. 




Donors Seven human pancreases recovered from donors with recent onset type 1 diabetes (disease duration ≤ 18 months) were selected from within a cohort used previously [8] and studied with ethical permission. The overall mean age was 16±5 years (Table 1) and causes of death were ketoacidosis (D1, 3, 5, 7 and 9) hypoglycaemia (D8) or glioma with raised intracranial pressure (D10). 
Immunohistochemistry Serial sections (4μm) were mounted on glass slides coated in (3-Aminopropyl)-triethoxysilane (Sigma-Aldrich, Dorset, UK) and stained using a combined immunoperoxidase and immunofluorescence technique [8]. The method was modified slightly for this study. Briefly, sections were de-waxed and rehydrated through a series of ethanol dilutions and finally dH2O. Heat-induced epitope retrieval was performed by immersion in 1mMol l-1 EDTA buffer (pH 8.0) in a pressure cooker and heating in a microwave oven on full power (800W) for 20 min followed by cooling at room temperature. 

Sections were  incubated with a primary antibody raised against the cell proliferation marker, Ki67 (mouse, 1:200, clone MIB1) and positive staining was detected with the Dako REAL™ Envision™ Detection System (Dako, Ely, Cambridgeshire, UK) using 3,3’-diaminobenzidine (DAB) as chromogen. Sections were counterstained with haematoxylin (Dako) before incubation with an antibody raised against the enteroviral capsid protein, vp1 (mouse, 1:500, clone 5D8/1), overnight at 4°C. This was detected with an Alexa Fluor® 568 conjugated goat anti-mouse secondary antibody. The sections were then incubated with guinea-pig anti-insulin antibody (1:600) followed by Alexa Fluor® 488 conjugated goat anti-guinea-pig secondary antibody. DAPI (1µg/ml) was included in this final step to stain cell nuclei. Controls were performed to confirm that deposition of the DAB product did not prevent the subsequent detection of insulin or vp1 by immunofluorescence. Adjacent sections were stained with rabbit anti-glucagon (1:300) using a standard immunoperoxidase technique. Antibody incubations were carried out for 1h at room temperature unless otherwise specified. Primary antibodies were purchased from Dako. DAPI and Alexa Fluor® conjugated secondary antibodies were purchased from Invitrogen (Paisley, UK). 

Analysis  Sections were analysed using a Nikon Eclipse 80i microscope (Nikon, Surrey, UK) under both brightfield and fluorescence illumination and scored for immunopositivity with relevant antisera. Statistical significance was assessed using a χ2 test.

Results
Details of the donors used in this study are presented in Table 1. Staining of a pancreas section from each donor for glucagon revealed that 1175 islets were present among the 7 individuals (Fig.1a). The number of islets per section ranged from 31-294 with a mean of 167.9 ± 38 islets/section. 359 of the 1175 islets were insulin-positive (30.1%) with a range of 24-103 per section. 
Staining of the sections for vp1 and insulin revealed that 72 of 1175 islets contained one or more vp1+ cells (6.1%; Fig 1a and 1b). Vp1 was present only in insulin-positive islets and the number of individual vp1+ cells ranged from 1-19 per islet.
Among the 1175 islets studied, 52 contained Ki67+ cells (4.4%) and 44 of these were insulin-containing islets. By virtue of their characteristic morphology, it was determined that a total of 98 individual islet cells were stained positively for Ki67. 52 of the 98 Ki67+ islet cells co-stained for insulin. The maximum number of Ki67+ cells found within any single islet was 5. 
Analysis of the population of islets which contained vp1+ and/or Ki67+ cells revealed that 28 were dual-positive for both antigens. Thus, the presence of these rarely produced proteins correlated strongly, in that 38.9% (28 of 72) of vp1+ islets also contained Ki67+ cells (p<0.05 by χ2).  When considered from the alternative perspective, this correlation is emphasised even more strongly, since 53.8% of Ki67+ islets (28 of 52) contained vp1+ cells (p<0.05 by χ2). Moreover, when account is taken of the fact that vp1 was only present in beta cells, the correlation strengthens still further with vp1 being produced in 63.6% (28 of 44) of Ki67+/insulin-containing islets but in less than 14% of Ki67-/insulin-containing islets. These relationships are illustrated diagrammatically in Fig.1b and an islet containing individual vp1+ cells and Ki67+ cells is shown in Fig 1c-f.
Despite the strongly positive correlation between the presence of vp1 and Ki67 among the total population of islets, no individual beta cells were dual-positive for both vp1 and Ki67 in any islet studied. 

Discussion
Recent studies have established that the enteroviral capsid protein, vp1, is present in a minority of beta cells in 60% of patients with recent-onset type 1 diabetes but is seen only very rarely in histologically normal pancreases of children dying of non-diabetic conditions [4]. This is consistent with an increasing body of evidence supporting the proposition that islet autoimmunity may be precipitated by enteroviral infection  ADDIN EN.CITE [9-10]. Despite this, it is clear that the infection occurring in islet cells in type 1 diabetes is atypical, since the large scale cell lysis normally associated with acute enteroviral infection in some tissues is not evident in the endocrine pancreas. Rather, it appears that a low level, persistent infection is established in which beta cell lysis is minimal (or absent) and only small numbers of beta cells produce viral protein within individual islets [4]. Given this situation, it is likely that a triggering event is required to re-activate viral protein synthesis and we hypothesised that this might be beta cell mitosis since there is evidence that enteroviral replication is facilitated in actively cycling cells [5]. However, the present results reveal that this is not the case since, despite the fact that Ki67 and vp1 could be readily detected in the islets of recent-onset type 1 diabetic patients, not a single beta cell was found, among 1175 islets examined, in which both proteins were co-expressed. This implies very strongly that a change in the proliferative state of the beta cells is not, itself, directly permissive for enteroviral vp1 production. Indeed, it may even be the case that beta cell proliferation precludes vp1 production during persistent infection, as was recently suggested in the nervous system  ADDIN EN.CITE [11].
One caveat to this conclusion concerns the possibility that enteroviral vp1 production might be initiated during mitosis at a different point in the cycle from that when expression of Ki67 occurs, such that the two do not overlap temporally. This is unlikely, since Ki67 is produced throughout the cell cycle and should persist during vp1 synthesis, if the latter also occurs during mitosis. Indeed, co-localisation of vp1 and Ki67 has been reported in other tissues  ADDIN EN.CITE [11-12]. Therefore, we conclude that, although beta cell mitosis is observed much more frequently in recent onset type 1diabetes than in controls, this is not the stimulus for enteroviral vp1 production. 
Despite the failure to detect co-production of Ki67 and vp1 in beta cells, we observed that Ki67 and vp1 were present within the same islets (albeit in different cells) at high frequency. One mechanism that could explain this relationship comes from earlier findings revealing that both enhanced endocrine cell proliferation and vp-1 correlated with insulitis. Insulitis was present  in 66% of islets containing Ki67+ endocrine cells [8] and in 38.5% of islets expressing vp1 [4], in patients with recent-onset type 1diabetes. A similar correlation has been reported between Ki67 and insulitis by Meier et al [13] but these authors did not monitor vp1 production.
 On this basis, we propose that the establishment of a persistent enteroviral infection of beta cells may represent an initiating event which leads to changes (such as chemokine secretion) that facilitate the infiltration of immune cells. The immune cells then release mitogens, including low concentrations of pro-inflammatory cytokines  ADDIN EN.CITE [14] that promote endocrine cell proliferation. 
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Donor	Age	Sex	Duration of T1D	Islets (n)	ICI (n)	vp1+ islets (n) (ICI (n))	Ki67+ islets (n) (ICI (n))	Ki67+ vp1+ Islets (n)
D1	1	F	3 days	183	48	10 (10)	12 (12)	7
D3	6	F	<1 week	31	24	6 (6)	2 (2)	1
D5	11	F	5 days	210	26	5 (5)	9 (6)	2
D7	15	M	6 months	294	33	3 (3)	5 (1)	0
D8	18	M	4 months	70	69	27 (27)	12 (12)	12
D9	23	M	2 weeks	113	103	5 (5)	3 (2)	0
D10	42	F	18 months	274	56	16 (16)	9 (9)	7
Total	NA	NA	NA	1175	359	72 (72)	52 (44)	29
ICI – Insulin-containing islets
NA – Not applicable
T1D – Type 1 diabetes
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